Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine
- 1 August 2002
- Vol. 20 (29-30) , 3456-3464
- https://doi.org/10.1016/s0264-410x(02)00350-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Makings of a Tumor Rejection AntigenImmunity, 1999
- The global burden of cancerSeminars in Cancer Biology, 1998
- Natural History of Cervicovaginal Papillomavirus Infection in Young WomenNew England Journal of Medicine, 1998
- Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort StudyThe Journal of Infectious Diseases, 1995
- Immunological Events in Regressing Genital WartsAmerican Journal of Clinical Pathology, 1994
- Cellular immunodeficiency enhances the progression of human papillomavirus‐associated cervical lesionsInternational Journal of Cancer, 1994
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Prophylactic and therapeutic vaccination against a mucosal papillomavirusJournal of General Virology, 1993
- Viruses in Human CancersScience, 1991
- Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat wartsCancer, 1986